BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 11813875)

  • 21. Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy.
    Shimizu M; Furuichi K; Toyama T; Kitajima S; Hara A; Kitagawa K; Iwata Y; Sakai N; Takamura T; Yoshimura M; Yokoyama H; Kaneko S; Wada T;
    Diabetes Care; 2013 Nov; 36(11):3655-62. PubMed ID: 24089538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of renal proximal tubular cells in diabetic nephropathy.
    Phillips AO
    Curr Diab Rep; 2003 Dec; 3(6):491-6. PubMed ID: 14611746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human GLP-1(rhGLP-1) alleviating renal tubulointestitial injury in diabetic STZ-induced rats.
    Yin W; Xu S; Wang Z; Liu H; Peng L; Fang Q; Deng T; Zhang W; Lou J
    Biochem Biophys Res Commun; 2018 Jan; 495(1):793-800. PubMed ID: 29137984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteopontin: correlation with interstitial fibrosis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells.
    Junaid A; Amara FM
    Histopathology; 2004 Feb; 44(2):136-46. PubMed ID: 14764057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis
    Li X; Zhang T; Geng J; Wu Z; Xu L; Liu J; Tian J; Zhou Z; Nie J; Bai X
    Antioxid Redox Signal; 2019 Sep; 31(7):521-538. PubMed ID: 31084358
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of intrarenal product TNF-alpha in the development of glomerular and tubulointerstitial tissues changes in elderly patients with diabetic nephropathy].
    Rakitianskaia IA; Riabov SI; Azanchevskaia SV; Riabova TS; Al-Barbari K; Gurkov AS; Popova VB
    Adv Gerontol; 2013; 26(4):658-65. PubMed ID: 24738256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and histological correlation of diabetic nephropathy.
    Afroz T; Sagar R; Reddy S; Gandhe S; Rajaram KG
    Saudi J Kidney Dis Transpl; 2017; 28(4):836-841. PubMed ID: 28748886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of diabetic nephropathy in type 1 diabetic patients.
    Najafian B; Mauer M
    Diabetes Res Clin Pract; 2009 Jan; 83(1):1-8. PubMed ID: 19070384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy.
    Krupa A; Jenkins R; Luo DD; Lewis A; Phillips A; Fraser D
    J Am Soc Nephrol; 2010 Mar; 21(3):438-47. PubMed ID: 20056746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.
    Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS
    Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ICAM-1 interactions in the renal interstitium: a novel activator of fibroblasts during nephritis.
    Clayton A; Steadman R
    Histol Histopathol; 1999 Jul; 14(3):861-70. PubMed ID: 10425556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Praliciguat inhibits progression of diabetic nephropathy in ZSF1 rats and suppresses inflammation and apoptosis in human renal proximal tubular cells.
    Liu G; Shea CM; Jones JE; Price GM; Warren W; Lonie E; Yan S; Currie MG; Profy AT; Masferrer JL; Zimmer DP
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F697-F711. PubMed ID: 32865013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in tubular epithelial cells in diabetic nephropathy.
    Habib SL
    J Nephrol; 2013; 26(5):865-9. PubMed ID: 24052469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
    Liu P; Li F; Qiu M; He L
    Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V; Kulkarni O; Clauss S; Anders H-
    Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation.
    Abbate M; Zoja C; Corna D; Capitanio M; Bertani T; Remuzzi G
    J Am Soc Nephrol; 1998 Jul; 9(7):1213-24. PubMed ID: 9644631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension and diabetic renal disease.
    Fioretto P; Steffes MW; Mauer SM
    Clin Invest Med; 1991 Dec; 14(6):630-5. PubMed ID: 1794213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R; Spinas GA
    Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norcantharidin attenuates tubulointerstitial fibrosis in rat models with diabetic nephropathy.
    Li Y; Chen Q; Liu FY; Peng YM; Hou T; Duan SB; Li J; Luo JH; Sun L; Ling GH
    Ren Fail; 2011; 33(2):233-41. PubMed ID: 21332346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.